May 31, 2022
Healthcare company
SCWorx Corp. has agreed to resolve SEC charges that it made false and misleading statements in an April, 2020 press release, claiming in a press release that it had received a purchase order for millions of COVID-19 rapid test kits. The announcement caused the company’s stock price to surge, but the SEC alleged that the company had neither a legitimate supplier of COVID-19 test kits nor an executed purchase agreement with a buyer. When the true facts became public, investors lost at least $116 million. The company has agreed to pay a civil penalty of
$125,000 and contribute stock valued at $600,000 as disgorgement and prejudgment interest to harmed investors in a private class action. The company’s former CEO,
Marc Schessel, has been indicted for securities fraud with respect to the scheme.
SEC;
USAO NJ